Continuous Glucose Monitoring Following Hospital Discharge

Running, not enrolling · Not applicable

Conditions studied: Type 2 Diabetes

In brief

In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patients will complete surveys assessing patient-reported outcomes prior to CGM use and following completion of the study. CGM data will be captured by the patient smartphone app and analyzed. Patients will receive personalized CGM targets and alerts for hyperglycemia and hypoglycemia. Customized reports/ decision support will be sent to the usual diabetes provider. The initial observational cohort study design will be followed by an extension phase of 12 weeks in which data on continuation of use and glucose control will be collected but no further reports will be communicated to providers.

Key facts

Study ID

NCT05360056

Run by

Kathleen Dungan

People needed

108

Starts

2022-04-26

Expected to finish

2027-01-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 Diabetes
• Basal insulin use >10 units per day
• Hemoglobin A1c >8.0%
• Smartphone compatible with Clarity App
• Age ≥18 years

You may not qualify if…

• Type 1 DM
• Inability to consent
• Pregnancy
• Prisoners
• Discharge to skilled nursing facility

Where it is running

• The Ohio State University Medical Center - Outpatient Care East — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.